CPT 0506T: Macular Pigment Optical Density Measurement with HFP

CPT code 0506T covers measurement of macular pigment optical density (MPOD) using heterochromic flicker photometry (HFP), including interpretation and reporting. The test quantifies lutein and zeaxanthin levels in the macula, biomarkers that are associated with protection against age-related macular degeneration and cataract. Nationally, this code represents an emerging diagnostic assessment used in ophthalmology and optometry to evaluate macular health and supplement risk stratification for degenerative retinal disease.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield plans, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for MPOD testing, expected sites of service (ophthalmology and optometry clinics or specialized vision diagnostic centers), and the types of information typically reported with this procedure. The publication also outlines benchmarks and payer coverage patterns where available, summarizes relevant policy updates affecting diagnostic ophthalmic testing, and highlights billing and documentation considerations tied to test interpretation and reporting. Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.

Billing Code Overview

CPT code 0506T describes measurement of macular pigment optical density (MPOD) using heterochromic flicker photometry (HFP) to determine the amount of lutein and zeaxanthin in macular pigment in one or both eyes. The procedure includes the measurement process as well as interpretation and report. Lutein and zeaxanthin are dietary carotenoids thought to play a protective role against age-related macular degeneration and cataract.

Service Type: Diagnostic retinal/ophthalmic imaging and functional testing
Typical Site of Service: Ophthalmology clinic, optometry clinic, or specialized vision diagnostic center

Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.

Clinical Context

A 68-year-old patient with early visual complaints and risk factors for age-related macular degeneration (AMD) is referred to a retinal specialist or ophthalmic diagnostic clinic for objective assessment of macular pigment. The patient undergoes macular pigment optical density (MPOD) testing using heterochromic flicker photometry (HFP). The clinical workflow includes: a pretest history and vision check by an ophthalmic technician, pupil status assessment, patient positioning at the HFP instrument, explanation of the subjective flicker task, performance of monocular or binocular measurements as indicated, immediate review of test traces by the technician, and formal interpretation and report by the provider. Results guide counseling about lutein/zeaxanthin status, nutritional supplementation considerations, and monitoring for AMD progression. Typical site of service is an outpatient ophthalmology clinic, retinal specialty practice, or vision diagnostics center. Service type is diagnostic physiological measurement with professional interpretation and report included under the procedure code 0506T.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the physician interpretation/report separate from technical component.

Taxonomy Code	Specialty	Notes
`207W00000X`	Ophthalmology	Retinal specialists commonly order and interpret MPOD testing.
`207WH0002X`	Vitreoretinal Surgery	Providers managing AMD and retinal disease often use MPOD data.
`174400000X`	Optometrist	Optometrists in specialty clinics may perform the measurement and provide counseling.
`261QM0800X`	Diagnostic Radiology (Ophthalmic Imaging)	Represents imaging/diagnostic services staff involved in testing.
`363LP0800X`	Eye Clinic/Diagnostic Services	Clinic-level taxonomy for facilities performing the technical component.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`H35.31`	Nonexudative age-related macular degeneration	MPOD testing assesses macular pigment which may relate to risk/progression in dry AMD.
`H35.32`	Exudative age-related macular degeneration	Measurement can be used to document macular pigment status in patients at risk for wet AMD.
`H52.4`	Presbyopia	General macular health assessment may be performed in older patients with presbyopia as part of comprehensive care.
`H54.7`	Unspecified visual loss	Evaluation of macular pigment can be part of workup for unexplained central visual changes.
`H28.9`	Disorder of lens, unspecified	Macular pigment assessment can accompany cataract evaluation when macular status may affect expected visual outcome.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`92250`	Fundus photography with interpretation and report	Often performed alongside MPOD testing to document macular appearance and correlate pigment density with fundus findings.
`92133`	Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report; optic nerve and retina (e.g., OCT)	OCT is commonly performed before or after MPOD to assess macular structure and AMD features.
`92227`	Remote imaging for detection of retinal disease; unilateral or bilateral	Telemedicine screening images may prompt in-office MPOD measurement for further risk stratification.
`92310`	Prescription of optical aids, low vision	In low-vision clinics, MPOD testing can be part of the diagnostic battery that informs low-vision rehabilitation planning.
`99000`	Handling and/or conveyance of specimen	Not specific to this procedure; Data not available in the input.

OpenPayer

Summary & Overview